MW 416.7 Da, Purity >98%. SOD/catalase mimetic. Consumes H2O2 with an initial reaction rate of 234 μM/min. Ameliorates nNOSμ translocation and skeletal muscle fiber atrophy during short-term mechanical unloading. Shows neuroprotective and anti-ischemic effects in vivo. .
81065-76-1
> 98%
Solid
416.7 Da
C18H18ClMnN2O4
45489809
Synthetic
MW 416.7 Da, Purity >98%. SOD/catalase mimetic. Consumes H2O2 with an initial reaction rate of 234 μM/min. Ameliorates nNOSμ translocation and skeletal muscle fiber atrophy during short-term mechanical unloading. Shows neuroprotective and anti-ischemic effects in vivo. .
81065-76-1
> 98%
Solid
416.7 Da
C18H18ClMnN2O4
45489809
Synthetic
Soluble in DMSO to 25 mM.
CID 45489809
SOD/catalase mimetic. Consumes H2O2 with an initial reaction rate of 234 μM/min. Ameliorates nNOSμ translocation and skeletal muscle fiber atrophy during short-term mechanical unloading. Shows neuroprotective and anti-ischemic effects in vivo.
COC1=CC=CC(=C1[O-])C=NCCN=CC2=C(C(=CC=C2)OC)[O-].[Cl-].[Mn+2]
InChI=1S/C18H20N2O4.ClH.Mn/c1-23-15-7-3-5-13(17(15)21)11-19-9-10-20-12-14-6-4-8-16(24-2)18(14)22;;/h3-8,11-12,21-22H,9-10H2,1-2H3;1H;/q;;+2/p-3
ZCNKLAVGNJEDNF-UHFFFAOYSA-K
manganese(2+);2-methoxy-6-[2-[(3-methoxy-2-oxidophenyl)methylideneamino]ethyliminomethyl]phenolate;chloride
Ambient - Can Ship with Ice
-20°C
-20°C
Store under desiccating conditions, The product can be stored for up to 12 months
This product is manufactured by BioVision, an Abcam company and was previously called 2175 EUK-134. 2175-25 is the same size as the 25 mg size of ab145593.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab145593, EUK 134, SOD/catalase mimetic
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com